UBS Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3M | Sell |
176,400
-66,482
| -27% | -$6.37M | ﹤0.01% | 2879 |
|
|
2025
Q4 | $23.3M | Sell |
242,882
-16,500
| -6% | -$1.6M | ﹤0.01% | 2437 |
|
|
2025
Q3 | $24.7M | Sell |
259,382
-15,500
| -6% | -$1.42M | ﹤0.01% | 2329 |
|
|
2025
Q2 | $24M | Sell |
274,882
-135,700
| -33% | -$11.5M | ﹤0.01% | 2180 |
|
|
2025
Q1 | $36.9M | Buy |
410,582
+57,782
| +16% | +$5.17M | 0.01% | 1752 |
|
|
2024
Q4 | $28.2M | Buy |
352,800
+55,200
| +19% | +$4.78M | 0.01% | 1971 |
|
|
2024
Q3 | $26.8M | Buy |
297,600
+46,000
| +18% | +$3.87M | 0.01% | 1601 |
|
|
2024
Q2 | $19.8M | Buy |
251,600
+69,400
| +38% | +$5.69M | ﹤0.01% | 1680 |
|
|
2024
Q1 | $15.9M | Buy |
182,200
+116,800
| +179% | +$9.97M | ﹤0.01% | 1870 |
|
|
2023
Q4 | $5.39M | Buy |
65,400
+65,000
| +16,250% | +$4.95M | ﹤0.01% | 2708 |
|
|
2023
Q3 | $31.3K | Hold |
400
| – | – | ﹤0.01% | 6573 |
|
|
2023
Q2 | $35.2K | Sell |
400
-216,800
| -100% | -$18.7M | ﹤0.01% | 6651 |
|
|
2023
Q1 | $17.5M | Sell |
217,200
-230,500
| -51% | -$18.8M | 0.01% | 1499 |
|
|
2022
Q4 | $34.8M | Sell |
447,700
-101,400
| -18% | -$8.22M | 0.01% | 1032 |
|
|
2022
Q3 | $44.3M | Buy |
549,100
+455,000
| +484% | +$40.9M | 0.02% | 755 |
|
|
2022
Q2 | $8.45M | Buy |
94,100
+33,000
| +54% | +$3.34M | ﹤0.01% | 1938 |
|
|
2022
Q1 | $6.78M | Sell |
61,100
-45,104
| -42% | -$4.77M | ﹤0.01% | 2260 |
|
|
2021
Q4 | $11M | Buy |
106,204
+32,305
| +44% | +$3.74M | ﹤0.01% | 2066 |
|
|
2021
Q3 | $9.26M | Hold |
73,899
| – | – | ﹤0.01% | 2084 |
|
|
2021
Q2 | $9.17M | Sell |
73,899
-552,500
| -88% | -$69.4M | ﹤0.01% | 2125 |
|
|
2021
Q1 | $74M | Buy |
626,399
+483,599
| +339% | +$56.7M | 0.02% | 636 |
|
|
2020
Q4 | $16.7M | Buy |
142,800
+112,800
| +376% | +$12.4M | 0.01% | 1467 |
|
|
2020
Q3 | $3.12M | Sell |
30,000
-12,100
| -29% | -$1.22M | ﹤0.01% | 2644 |
|
|
2020
Q2 | $3.86M | Sell |
42,100
-5,400
| -11% | -$518K | ﹤0.01% | 2246 |
|
|
2020
Q1 | $4.28M | Sell |
47,500
-45,400
| -49% | -$4.83M | ﹤0.01% | 2061 |
|
|
2019
Q4 | $10.5M | Sell |
92,900
-76,100
| -45% | -$8.35M | ﹤0.01% | 1911 |
|
|
2019
Q3 | $18.4M | Sell |
169,000
-361,100
| -68% | -$37.7M | 0.01% | 1308 |
|
|
2019
Q2 | $51.6M | Buy |
530,100
+522,600
| +6,968% | +$47.7M | 0.02% | 654 |
|
|
2019
Q1 | $683K | Sell |
7,500
-77,800
| -91% | -$6.96M | ﹤0.01% | 3846 |
|
|
2018
Q4 | $7.76M | Buy |
85,300
+15,100
| +22% | +$1.41M | ﹤0.01% | 1786 |
|
|
2018
Q3 | $6.91M | Sell |
70,200
-6,900
| -9% | -$638K | ﹤0.01% | 2076 |
|
|
2018
Q2 | $6.6M | Buy |
77,100
+9,000
| +13% | +$752K | ﹤0.01% | 2105 |
|
|
2018
Q1 | $5.46M | Sell |
68,100
-120,000
| -64% | -$9.9M | ﹤0.01% | 2218 |
|
|
2017
Q4 | $15.2M | Buy |
188,100
+176,600
| +1,536% | +$14.1M | 0.01% | 1378 |
|
|
2017
Q3 | $894K | Hold |
11,500
| – | – | ﹤0.01% | 3796 |
|
|
2017
Q2 | $1.02M | Sell |
11,500
-1,100
| -9% | -$92.8K | ﹤0.01% | 3594 |
|
|
2017
Q1 | $1.01M | Sell |
12,600
-17,600
| -58% | -$1.37M | ﹤0.01% | 3519 |
|
|
2016
Q4 | $2.15M | Hold |
30,200
| – | – | ﹤0.01% | 2858 |
|
|
2016
Q3 | $2.61M | Sell |
30,200
-478
| -2% | -$41.7K | ﹤0.01% | 2605 |
|
|
2016
Q2 | $2.66M | Sell |
30,678
-143,522
| -82% | -$11.6M | ﹤0.01% | 2526 |
|
|
2016
Q1 | $13.1M | Buy |
174,200
+140,000
| +409% | +$10.5M | 0.01% | 1152 |
|
|
2015
Q4 | $2.63M | Sell |
34,200
-27,000
| -44% | -$2.03M | ﹤0.01% | 2547 |
|
|
2015
Q3 | $4.1M | Sell |
61,200
-276,400
| -82% | -$20.4M | ﹤0.01% | 2084 |
|
|
2015
Q2 | $25M | Buy |
337,600
+177,600
| +111% | +$13.6M | 0.02% | 838 |
|
|
2015
Q1 | $12.5M | Sell |
160,000
-1,029,100
| -87% | -$78M | 0.01% | 1298 |
|
|
2014
Q4 | $85.9M | Buy |
+1,189,100
| New | +$82.6M | 0.06% | 331 |
|
Other funds holding MDT
VCM
VPM
UBS Group's MDT Position: Q1 2026 in Review
UBS Group increased its Medtronic (MDT) stake by 54% in Q1 2026, buying an estimated $215M and bringing the position to 6,412,252 shares worth $556M. The position accounts for 0.08% of the portfolio, ranked #245.
UBS Group first reported a position in MDT in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.7B in Q4 2019. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- UBS Group held 6,412,252 shares of Medtronic worth $556M as of Q1 2026.
- UBS Group bought 2,241,365 Medtronic shares in Q1 2026, an estimated $215M.
- Medtronic made up 0.08% of UBS Group's portfolio in Q1 2026, its #245 holding.
- UBS Group first reported a position in Medtronic in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Medtronic position peaked at $1.7B in Q4 2019.
- 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.